A welcome study from Belgium showing that Penthrox provides substantial time and cost savings per patient in emergency care. The study is based on several assumptions, one of which is government reimbursement. This is why it is so important we get government reimbursement in Germany.
https://www.researchgate.net/profile/Said-Hachimi-Idrissi/publication/350468965_Healthcare_resource_use_and_cost_implications_of_low_dose_methoxyflurane_for_severe_trauma-related_pain_a_qualitative_study/links/6062f83392851cd8ce76693a/Healthcare-resource-use-and-cost-implications-of-low-dose-methoxyflurane-for-severe-trauma-related-pain-a-qualitative-study.pdf
Another Positive Study, page-3
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
-0.020(4.49%) |
Mkt cap ! $36.68M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 44.5¢ | 42.5¢ | $31.32K | 72.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2254 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 111906 | 1 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
43.0¢ |
Change
-0.020 ( 1.92 %) |
||||
| Open | High | Low | Volume | ||
| 43.5¢ | 44.0¢ | 43.0¢ | 11196 | ||
| Last updated 15.47pm 13/05/2024 ? | |||||
| MVP (ASX) Chart |